Allowed to import non-approved drugs. Once approved, not allowed to import drugs. This 150 pounds is $194. Compare to $1035 in the US. That $50 shot likely provides a big  profit. 

https://www.medexpress.co.uk/clinics/weight-loss/mounjaro

You should ask your political representatives to demand the PA Medicaid negotiate the highly profitable price of $40 a pen, not $250. From a high school Economics 101  view, demand will explode, and the drug companies will become more profitable. Box of 4 pens is $83 in France. Come on, man. 

https://www.advisory.com/daily-briefing/2023/08/21/weight-loss-drug-cost

***********************

This is the AUDIT scale for alcoholism. A 4 is normal, 9 is of concern. he selected patients had scores of 13. 

https://nida.nih.gov/sites/default/files/files/AUDIT.pdf

Current FDA  approved meds for alcohol addiction have a 5% long term success rate. 

They improve glucose metabolism by nerve cells, so help people with Parkinson's, Alzheimer, and depression. As they cut food consumption in half, so they appear to cut alcohol consumption in half. Cochrane Review: 

https://pubmed.ncbi.nlm.nih.gov/35054924/

From:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684505/

"Here we provide a principled analysis of social media posts detailing a reduction in alcohol consumption while taking GLP-1 and Tirzepatide medication. In addition, we report a reduction in average number of drinks, binge drinking, AUDIT score, and the sedative/stimulating effects of alcohol in individuals taking Semaglutide or Tirzepatide in our remote study. These findings add to a growing literature detailing a reduction in alcohol intake after GLP-1 agonist medications. To our knowledge this is the first report of decreased alcohol consumption following Tirzepatide use. Further RCTs are needed to fully explore the therapeutic potential of GLP-1 agonists and GIP/GLP-1 combination drugs for the treatment of Alcohol Use Disorder."

People were less drunk when they drank. 

See Tables C and D for the AUDIT scores.